Minerva Neurosciences (NERV) Cash from Financing Activities (2013 - 2026)
Minerva Neurosciences (NERV) reported Cash from Financing Activities of $1.1 million for Q1 2026, down 98.55% quarter-over-quarter from $74.5 million in Q4 2025.
Minerva Neurosciences (NERV) Cash from Financing Activities (2013 - 2026) Analysis & Trends
Minerva Neurosciences has reported Cash from Financing Activities for 12 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $75.5 million (changed N/A YoY), and the FY2025 full-year result was $74.5 million, changed N/A from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $1.1 million, down from $74.5 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $74.5 million in Q4 2025, with the low at -$86691.0 in Q3 2023.
- Historically, Cash from Financing Activities has averaged $19.0 million across 3 years, with a median of $1.1 million in 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 53,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 85,464.43 |
| 10 | Minerva Neurosciences | 197.55 Mn | 197.55 Mn | - | 1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 74.50 Mn |
| Dec 31, 2025 | 74.50 Mn |
| Sep 30, 2025 | -45,166.00 |
| Sep 30, 2025 | -45,166.00 |
| Sep 30, 2023 | -86,691.00 |
| Sep 30, 2023 | -86,691.00 |
| Jun 30, 2023 | 19.69 Mn |
| Jun 30, 2023 | 19.69 Mn |
| Mar 31, 2021 | 60.00 Mn |
| Mar 31, 2021 | 60.00 Mn |
| Sep 30, 2020 | 7.14 Mn |
| Sep 30, 2020 | 7.14 Mn |
| Jun 30, 2020 | 5.30 Mn |
| Jun 30, 2020 | 5.30 Mn |
| Mar 31, 2020 | 797,629.00 |
| Mar 31, 2020 | 797,629.00 |
| Dec 31, 2019 | -1.00 |
| Dec 31, 2019 | -1.00 |